Vaishali Pharma Ltd

VAISHALI
Health CarePharmaceuticals
SmallcapWith a market cap of ₹85 cr, stock is ranked 2,203
High RiskStock is 3.99x as volatile as Nifty
80.750.60 (-0.74%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹85 cr, stock is ranked 2,203
High RiskStock is 3.99x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
81.89
PB RatioPB Ratio
3.80
Dividend YieldDiv. Yield
Sector PESector PE
33.53
Sector PBSector PB
4.83
Sector Div YldSctr Div Yld
0.83%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Vaishali Pharma Limited is a pharmaceutical company engaged in dealing in pharmaceutical formulations, active pharmaceutical ingredient (APIs), surgical products, veterinary supplements, and herbal and nutraceutical products

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201820192020202169.4277.0762.2655.580.800.700.021.04
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 29.56%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Press Release 
Announced OnApr 19, 2022

Vaishali Pharma Limited has informed the Exchange about press release dated 19-Apr-2022 titled SIGN UNIQUE PARTNERSHIP AGREEMENT, A FIRST IN NUTRACEUTICALS MARKET | Download

Vaishali Pharma Limited has informed the Exchange about press release dated 19-Apr-2022 titled SIGN UNIQUE PARTNERSHIP AGREEMENT, A FIRST IN NUTRACEUTICALS MARKET | Download

General updates 
Announced OnApr 18, 2022

Vaishali Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Vaishali Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Price movement 
Announced OnApr 11, 2022

VAISHALI : Significant movement in price has been observed in Vaishali Pharma Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Vaishali Pharma Limited has submitted their response. | Download

VAISHALI : Significant movement in price has been observed in Vaishali Pharma Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Vaishali Pharma Limited has submitted their response. | Download

See all events